CVE:EVEEve & Co Inc Stock Price, Forecast & News

C$0.08

0.00 (0.00 %)

(As of 05/29/2020 08:36 AM ET)

Add

Compare

Today's Range

C$0.08

Now: C$0.08▼

C$0.09

50-Day Range

C$0.07

MA: C$0.08▼

C$0.12

52-Week Range

C$0.07

Now: C$0.08▼

C$0.59

Volume499,689 shs

Average Volume625,862 shs

Market CapitalizationC$21.32 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Eve & Co Incorporated, through its subsidiary, Natural MedCo Ltd., produces and sells dried cannabis, cannabis plants, and cannabis seeds in Canada. It focuses on the distribution of recreational cannabis for women under the EVE brand. The company is headquartered in Strathroy, Canada.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Eve & Co Inc has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$0.54, Eve & Co Inc has a potential upside of 575.0% from its current price of C$0.08.
Amount of Analyst Coverage
Eve & Co Inc has received no research coverage in the past 90 days.

4.3 Community Rank

Outperform Votes
Eve & Co Inc has received 52 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Eve & Co Inc has received 9 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Eve & Co Inc has received 85.25% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Eve & Co Inc and other stocks. Vote “Outperform” if you believe EVE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EVE will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Eve & Co Inc does not currently pay a dividend.
Dividend Growth
Eve & Co Inc does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Eve & Co Inc insiders have not sold or bought any company stock.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Eve & Co Inc are expected to decrease by -100.00% in the coming year, from C$0.01 to C$0.00 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Eve & Co Inc is -2.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Eve & Co Inc is -2.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Eve & Co Inc has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.69 out of 5 stars

Industry, Sector and Symbol

Stock Exchange CVE

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolCVE:EVE

Previous Symbol

CUSIPN/A

CIKN/A

Webevecannabis.ca

Phone416-922-9096

Debt

Debt-to-Equity Ratio51.91

Current Ratio1.83

Quick Ratio0.77

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E Ratio8.00

P/E GrowthN/A

Sales & Book Value

Annual SalesC$413,711.00

Price / Sales51.53

Cash FlowC$0.02 per share

Price / Cash Flow3.21

Book ValueC$0.12 per share

Price / Book0.68

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding Shares266,468,000

Market CapC$21.32 million

Next Earnings Date8/13/2020 (Estimated)

OptionableNot Optionable

Receive EVE News and Ratings via Email

Sign-up to receive the latest news and ratings for EVE and its competitors with MarketBeat's FREE daily newsletter.

Eve & Co Inc (CVE:EVE) Frequently Asked Questions

How has Eve & Co Inc's stock been impacted by COVID-19 (Coronavirus)?

Eve & Co Inc's stock was trading at C$0.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EVE shares have decreased by 11.1% and is now trading at C$0.08. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Eve & Co Inc?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eve & Co Inc in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Eve & Co Inc.

When is Eve & Co Inc's next earnings date?

Eve & Co Inc is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Eve & Co Inc.

How were Eve & Co Inc's earnings last quarter?

Eve & Co Inc (CVE:EVE) issued its quarterly earnings data on Thursday, April, 16th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm earned $0.65 million during the quarter. View Eve & Co Inc's earnings history.

What price target have analysts set for EVE?

1 brokers have issued 12-month price targets for Eve & Co Inc's stock. Their forecasts range from C$0.54 to C$0.54. On average, they anticipate Eve & Co Inc's stock price to reach C$0.54 in the next twelve months. This suggests a possible upside of 575.0% from the stock's current price. View analysts' price targets for Eve & Co Inc.

Has Eve & Co Inc been receiving favorable news coverage?

News coverage about EVE stock has trended somewhat positive on Friday, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Eve & Co Inc earned a news impact score of 0.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutEve & Co Inc.

Who are some of Eve & Co Inc's key competitors?

Some companies that are related to Eve & Co Inc include Flowr (FLWR), Depomed (ASRT), Acerus Pharmaceuticals (ASP), MMJ Group (MMJ), Venture Life Group (VLG), Biosyent (RX), Auscann Group (AC8), InMed Pharmaceuticals (IN), Science in Sport (SIS), cbdMD (YCBD), Invion (IVX), Pediapharm (MDP), Diurnal Group (DNL), Viridium Pacific Group (VIR) and Zomedica Pharmaceuticals (ZOM). View all competitors.

What other stocks do shareholders of Eve & Co Inc own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eve & Co Inc investors own include Bellatrix Exploration (BXE), Aurora Cannabis (ACB), Co-Diagnostics (CODX), EVIO (EVIO), Dave & Buster's Entertainment (PLAY), Rubicon Minerals (RBYCF), Canopy Growth (WEED), Enbridge (ENB), Medical Facilities (DR) and Canadian Imperial Bank of Commerce (CM).

Who are Eve & Co Inc's key executives?

Eve & Co Inc's management team includes the following people:

Ms. Melinda Rombouts, Founder, CEO & Pres
Mr. David Burch, Founder
Mr. Landon Roedding, Chief Financial Officer
Mr. Richard M. Kimel, Corp. Sec. (Age 52)

What is Eve & Co Inc's stock symbol?

Eve & Co Inc trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EVE."

How do I buy shares of Eve & Co Inc?

Shares of EVE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Eve & Co Inc's stock price today?

One share of EVE stock can currently be purchased for approximately C$0.08.

How big of a company is Eve & Co Inc?

Eve & Co Inc has a market capitalization of C$21.32 million and generates C$413,711.00 in revenue each year.

What is Eve & Co Inc's official website?

The official website for Eve & Co Inc is evecannabis.ca.

How can I contact Eve & Co Inc?

The company can be reached via phone at 416-922-9096.

This page was last updated on 5/29/2020 by MarketBeat.com Staff